Literature DB >> 21252332

HIV prevention in women: next steps.

Sten H Vermund, Lut Van Damme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21252332     DOI： 10.1126/science.331.6015.284-a

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  12 in total

Review 1.  A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection.

Authors:  Tanuja N Gengiah; Cheryl Baxter; Leila E Mansoor; Ayesha Bm Kharsany; Salim S Abdool Karim
Journal:  Expert Opin Investig Drugs       Date:  2012-03-07       Impact factor: 6.206

Review 2.  Microbicides: still a long road to success.

Authors:  Christophe Vanpouille; Anush Arakelyan; Leonid Margolis
Journal:  Trends Microbiol       Date:  2012-06-15       Impact factor: 17.079

3.  Safety and tolerability of tenofovir for preexposure prophylaxis among men who have sex with men.

Authors:  Sten H Vermund
Journal:  J Acquir Immune Defic Syndr       Date:  2013-09-01       Impact factor: 3.731

Review 4.  Preexposure prophylaxis for HIV prevention.

Authors:  Theodoros Kelesidis; Raphael J Landovitz
Journal:  Curr HIV/AIDS Rep       Date:  2011-06       Impact factor: 5.071

5.  One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidates.

Authors:  Paul W Denton; Florence Othieno; Francisco Martinez-Torres; Wei Zou; John F Krisko; Elisa Fleming; Sima Zein; Daniel A Powell; Angela Wahl; Youn Tae Kwak; Brett D Welch; Michael S Kay; Deborah A Payne; Philippe Gallay; Ettore Appella; Jacob D Estes; Min Lu; J Victor Garcia
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Implementing microbicides in low-income countries.

Authors:  Tanuja N Gengiah; Quarraisha Abdool Karim
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2012-04-11       Impact factor: 5.237

7.  Vaginal deployment and tenofovir delivery by microbicide gels.

Authors:  Y Gao; A Yuan; O Chuchuen; A Ham; K H Yang; D F Katz
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

8.  Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV Transmission.

Authors:  Martina Kovarova; Olivia D Council; Abhijit A Date; Julie M Long; Tomonori Nochi; Tomonori Nochii; Michael Belshan; Annemarie Shibata; Heather Vincent; Caroline E Baker; William O Thayer; Guenter Kraus; Sophie Lachaud-Durand; Peter Williams; Christopher J Destache; J Victor Garcia
Journal:  PLoS Pathog       Date:  2015-08-13       Impact factor: 6.823

9.  Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1.

Authors:  Karen W Buckheit; Robert W Buckheit
Journal:  Mol Biol Int       Date:  2012-07-12

10.  Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel.

Authors:  Yajing Gao; David F Katz
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.